Pharmaceuticals
Japan's Eisai to invest in U.S. Alzheimer's blood testing firm C2N
Expanded use of tests could boost drugmaker's lecanemab medication
Australia's fourth-largest lender letting go of shares worth worth up to $242m
Japan steelmaker aims to complete purchase before November presidential election
Home Credit Vietnam acquisition part of overseas push for Siam Bank parent
Fervo repurposes drilling technology to develop renewable energy reserves
Welcia and Tsuruha unite to expand in Asia and capture demand from aging population
Deal to create India's largest television company
Foreign funds, big restaurant operators expected to submit bids
Japan's largest power generator makes its biggest overseas LNG acquisition
Australian financial group looks to ride Japanese M&A boom: Verena Lim
Curi RMB calls for reconsidering other buyout offers, requests more disclosure
Used-car chain faces split into 2 companies amid restructuring
Joint venture will invest $150m to make industrial robots, with aim of opening in December
E-commerce giant faces mounting competition from peers such as Pinduoduo
Deal to combine two of the largest credit card companies in the U.S.
Company has been hit by faltering demand for outdoor goods and rising costs
Altium acquisition highlights shift to providing complete development environment
Analysts expect Nippon Steel decision to be delayed until after presidential election
Power of clubby local tycoons discourages companies from entering market
Chipmaker to pay 34% premium for developer of printed-circuit board design tools
Merger was scrapped after two years of negotiations
Corporate valuation process has to be made more transparent and fair
German chemicals group says audits have not found any evidence of violations
Reverse breakup fee becomes possibility as takeover faces political opposition
Life insurer to pay $2bn to Pasona Group for employee benefits provider
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.